echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > 7th CHS 7th China Health Industry Upgrading Summit Theme Release: Two-way Innovation

    7th CHS 7th China Health Industry Upgrading Summit Theme Release: Two-way Innovation

    • Last Update: 2022-04-16
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    The new round of medical industry reform is vigorous and in full swing, and the relationship between the ancient and traditional industry and new technologies in the medical and health industry has gradually changed from a collision of differences to a cross-integration
    .
    The fundamental logic behind it has not changed, and it is still the driving force brought about by the acceleration of the aging process of China's population and the increase in national health needs.
    The battle without gunpowder has also entered a new stage of development
    .


    When innovation has become normalized, we have begun to reflect on the relationship between various elements in the medical and health industry while adapting to the pace
    .


    As the 7th China Health Industry Upgrade Summit is about to be held, Yiou Health concluded that the development of the medical and health industry is showing a trend of "two-way innovation", "doctors and patients, inside and outside the hospital, technology and clinical, reality".
    It is integrated with the core elements of the industry such as virtual, capital and industry, supervision and grassroots, domestic and foreign", and is achieving a deeper level of innovation and upgrading
    .


    From the perspective of demand, the national demand for medical and health has shifted from treating diseases as the core demand, and expanding forward and backward to the whole-process management needs from prevention to rehabilitation, and the places where medical and health occur will also expand from the hospital to the outside.
    , in-hospital treatment, out-of-hospital prevention and rehabilitation; with the blessing of new technologies such as the Internet, big data, wearable devices, and the awakening of patients' self-conscious health awareness, future medical care will develop towards a patient-centered orientation
    .

     
    In the future, the medical and health industry will also show a combination of reality and virtuality.
    The emerging new concepts of the metaverse will be realized in the medical and health scene.
    In the metaverse, we may be able to solve the reality of the medical industry through new technologies.
    unsolvable problems
    .
    Reconstructing the relationship between doctors and patients, medical care and society in the metaverse, reconstructing the big data generated around patients, establishing the connection between the real and virtual worlds, and finally realizing the medical metaverse, which will generate great value
    .

     
    What is happening now is actually the redefinition of the original medical and health scene and its value by new technology.
    The reshaping of this industry and the upgrading and development of the industry complement each other.

    .
    Driven by new technologies, a large number of innovative companies and products have emerged in the market.
    The upgrading and development of the industry has enabled the realization of the blueprint for future medical care, and promoted the reshaping of the patient-centered industry structure, and new patterns have been continuously born.
    demand, which in turn spurs further changes in the industry
    .

     
    In this virtuous cycle of development, the industry has achieved remarkable results.
    The traditional pharmaceutical industry has developed by leaps and bounds in recent years.

    China's pharmaceutical innovation ecosystem has initially formed, and the pharmaceutical innovation industry has flourished and continuously integrated with the global innovation industry chain; A situation of multi-point innovation is also being realized.
    Moreover, in the development of new industries such as AI imaging and digital therapy, many excellent domestic innovative companies have emerged on the international stage and exerted their value around the world; under the influence of the epidemic, the wave of digitalization With the sweeping, various segments of medical and health care have been subverted or upgraded, and a series of emerging digital + industrial tracks have been born; new technological applications such as mRNA and synthetic biology are also realizing a multi-point blooming situation
    .

     
    The interaction between industry and capital is also showing a new trend.
    Capital is participating in industrial transformation in a more active way, helping scientists convert more scientific research results into clinical applications; in addition, the important role in the medical and health industry, The payer is also undergoing major changes.
    While the national medical insurance is optimizing the structure of "removing the cage and replacing the bird", the social medical innovation payment model is also innovating.
    The combination of the two can alleviate the medical payment problem in an all-round way
    .

     
    In this context, as an observer and recorder of the big health industry, Yiou Big Health will hold the [Tianfu Talk] CHS 2022 7th China Big Health Industry Upgrade in Chengdu from September 24th to 25th.
    The summit consists of a main forum and 7 sub-forums, focusing on "digital medicine", "innovative medicine", "digital therapy", "synthetic biology" and "non-public healthcare and payment", "medical investment", " Specialized, Specialized and New" 7 themes, and a "National Health and Medical Big Data Application Management Training Course" was set up to discuss innovation with innovators, investors and other experts in the big health ecosystem
    .

     
     
    -Tianfu
    Chat CHS2022 registration is now open, guests are confirmed one after another, so stay tuned!
    Registration link: https://appBo0JH4qL2794.
    h5.
    xiaoeknow.
    com/mp/eyJpZCI6IjI3ODA0NTIifQ

     
    Business cooperation consultation:
    Tao Qiong T: 13683302568 E: taoqiong@iyiou.
    com
    Media cooperation consultation: Sun Lin T: 13121389596 E: sunlin@iyiou.
    com
    Audience registration consultation: Liu Jiayi T: 13330070672 E: liujiayi@iyiou.
    com





















    https://appBo0JH4qL2794.
    h5.
    xiaoeknow.
    com/mp/eyJpZCI6IjI3ODA0NTIifQ
    https://appBo0JH4qL2794.
    h5.
    xiaoeknow.
    com/mp/eyJpZCI6IjI3ODA0NTIifQ






    A series of studies on new coronary pneumonia have made outstanding progress
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.